However, Kolhai et al. reported an increase in the miR-155 levels in BD patients, in concomitance with a reduction of Ets-1 and an elevation of Th17 cells, suggesting a pro-inflammatory role and a potential therapeutic target [103]. The gene discussed is ETS1; the disease is Behcet disease.